| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-007-0747-2 |
| P698 | PubMed publication ID | 17909741 |
| P50 | author | Pawel Hrycaj | Q114341133 |
| Anna Olewicz-Gawlik | Q115325999 | ||
| P2093 | author name string | Izabela Korczowska | |
| Jakub Trefler | |||
| Jan Krzysztof Łacki | |||
| P2860 | cites work | Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures? | Q30930111 |
| Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy | Q33529337 | ||
| Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis | Q33565442 | ||
| Microheterogeneity of alpha 1-acid glycoprotein in patients with rheumatoid arthritis | Q33566514 | ||
| Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis | Q33578499 | ||
| Glucocorticosteroids in the management of rheumatoid arthritis | Q33639228 | ||
| Clinical utility of biochemical markers of bone remodeling | Q33701899 | ||
| Management of corticosteroid-induced osteoporosis | Q33857195 | ||
| Rheumatoid arthritis and osteoporosis | Q33894086 | ||
| The stimulation of lymphocytes by chondrocytes in mixed cultures | Q34008951 | ||
| The mortality of rheumatoid arthritis | Q34338843 | ||
| Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion | Q34569315 | ||
| Glucocorticoid use in rheumatoid arthritis | Q34637325 | ||
| Glucocorticoids in rheumatoid arthritis: effects on erosions and bone | Q34735524 | ||
| Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes | Q35594766 | ||
| Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes | Q35824517 | ||
| Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment | Q36606710 | ||
| Cytokines and osteoporosis | Q37591502 | ||
| Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease | Q39748604 | ||
| Management of the patient with severe refractory rheumatoid arthritis: are the newer treatment options worth considering? | Q40151089 | ||
| Rheumatoid arthritis: a medical emergency? | Q40597560 | ||
| Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases | Q40836795 | ||
| Modulation of osteoclast differentiation by local factors | Q40957420 | ||
| IL-6 is produced by osteoblasts and induces bone resorption | Q41714818 | ||
| Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial | Q43845375 | ||
| Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids | Q45062371 | ||
| The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin | Q45249079 | ||
| Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. | Q45274056 | ||
| The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis. | Q46492162 | ||
| Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis | Q47794776 | ||
| Loss of cortical bone from the metacarpal diaphysis in patients with rheumatoid arthritis: independent effects of systemic inflammation and glucocorticoids. | Q48507536 | ||
| How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy. | Q50963957 | ||
| Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis | Q64448949 | ||
| Osteopenia in rheumatoid arthritis: a biochemical, hormonal and histomorphometric study | Q68774197 | ||
| Effect of a interleukin-1 like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes | Q68793739 | ||
| Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis | Q70749141 | ||
| Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: Preliminary report | Q72033127 | ||
| Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone | Q72177611 | ||
| The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women | Q72607840 | ||
| Low serum vitamin D metabolites in women with rheumatoid arthritis | Q72891603 | ||
| Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis | Q73069498 | ||
| Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers | Q74252574 | ||
| Osteoporosis in rheumatoid arthritis | Q74425550 | ||
| P433 | issue | 5 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| glucocorticoid | Q422549 | ||
| osteoporosis | Q165328 | ||
| P304 | page(s) | 565-572 | |
| P577 | publication date | 2007-10-02 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients? | |
| P478 | volume | 27 |
| Q40079134 | Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study |
| Q42976143 | Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica |
| Q55176337 | Lean Mass and Disease Activity are the Best Predictors of Bone Mineral Loss in the Premenopausal Women with Rheumatoid Arthritis. |
| Q82732857 | Osteoporosis in psoriatic arthritis: is there any? |
| Q84072900 | Peripheral bone density in patients with rheumatoid arthritis |
| Q33648507 | Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis |
| Q46121066 | Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis |
| Q51366871 | The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis. |
| Q58329681 | Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study |
Search more.